In a recent Surveillance, Epidemiology, and End Results program research conducted on 740, 990 persons, it was concluded that about 25 persons of older adults and 11 percent of younger adults diagnosed with cancer had a history of cancer. In other words, as the number of cancer survivors keeps growing, understanding the nature of prior cancer is important when it comes to improving the clinical trial accrual and patient experience.
The goal of this study was to analyze the prevalence of prior cancer among persons who have previously been diagnosed with cancer as the population of cancer survivors keeps growing across the United States. The people who were analyzed in the research are individuals who have been diagnosed with cancer between January 2009 and December 2013.
Prevalence of cancer was derived from Surveillance, Epidemiology, and End Results (SEER) sequence numbers of 740,990 persons. The incident cancers were categorized as follows:
• First or only primary
• Second order or higher primary in the same cancer site
• Second order or higher primary in different cancer site
The results indicated that 18.4 percent of the 765, 843 incident cancers that were reported during that period represented a second order or higher primary cancer. In general 25.2 percent of older adults and 11 percent of younger adults had a history of cancer.
Eric Lefkofsky is a co-founder of Tempus, which is a technology company that has innovatively built an operating system that enables physicians to fight cancer more effectively. Through a machine learning platform, physicians can interactively analyze and deliver personalized care for cancer patients. The molecular and clinical data that is collected about cancer survivors is analyzed to provide vital insights for the treatment of future cancer cases. Since Lefkofsky graduated from the University of Michigan, he has worked tirelessly together with his team of dedicated individuals who share the same ambitions in achieving great success in his career.
Visit More : https://www.tempus.com/about-us/